1. PLANNING COMMITTEE
Jaime Estrada, MD – Committee Chair
Pediatric Specialist of Texas, San Antonio, TX
Karen Albritton, MD
Cook Children’s Hospital, Fort Worth, TX
Jennifer Carrera, LCSW
Methodist Healthcare, San Antonio, TX
Ka Wah Chan, MD
Texas Transplant Physicians Group, San Antonio, TX
Leanne Embry, PhD
University of Texas Health Science Center, San Antonio, TX
Sue Ellen Erdely, LCSW
Methodist Healthcare, San Antonio, TX
David Friedman, MD, PhD
US Oncology, San Antonio, TX
Anne-Marie Langevin, MD
University of Texas Health Science Center, San Antonio, TX
Wendy Macias, BA
Methodist Healthcare, San Antonio, TX
Brad Pollock, MPH, PhD
University of Texas Health Science Center, San Antonio, TX
Gerardo Quezada, MD
Pediatric Specialists of Texas, San Antonio, TX
Nancy Tena, MSN, RN, CNS-BC, CPON
Methodist Children’s Hospital, San Antonio, TX
Gail E. Tomlinson, MD, PhD
Greehey Children’s Cancer Research Institute, San Antonio, TX

2. PLANNING COMMITTEE DISCLOSURE
Methodist Healthcare controls the content and production of its CME activities and attempts to
assure the presentation of balanced, objective information. In accordance with the Standards
for Commercial Support established by the Accreditation Council for Continuing Medical
Education, the speakers have been asked to disclose any interest or affiliation with the
manufacturers of products or devices, which may be discussed in this presentation.
Speaker: Affiliation or Name of Company Conflict
Financial Interest: Resolved
Karen Albritton, MD Grant/Research Cure Search Yes
Jennifer Carrera, LCSW N/A
Ka Wah Chan, MD Stock (100 shares) Genzyme Yes
Leann Embry, PhD N/A
Sue Erdely, LCSW N/A
Jaime Estrada, MD NA
David Friedman, MD, PhD NA
Anne-Marie Langevin, MD N/A
Wendy Macias, BA N/A
Brad Pollock, MPH, PhD N/A
Gerardo Quezada, MD N/A
Nancy Tena, MSN, RC, CPON N/A
Gail Tomlinson, MD, PhD N/A
The following Methodist Healthcare CME Committee members reviewed and approved the
application. They have nothing to disclose:
Kenneth Davis, MD
Stephen Gill, MD
Paula Larson, MD

3. FACULTY
Karen Albritton, MD, Cook Children’s Hospital, Fort Worth, TX
Ronald Barr, MB, ChB, MD, McMaster University, Hamilton, Ontario, Canada
Archie Blyer, MD, St. Charles Cancer Care, Bend, OR
Sage Bolte, LCSW, Life With Cancer, Fairfax, VA
Anu Dham, MD, US Oncology, San Antonio, TX
Conrad Fernandez, MD, IWK Health Centre, Halifax, Nova Scotia, Canada
Joan Haase, RN, PhD, FAAN, Indiana University School of Nursing Indianapolis,
IN
Ruth Anne Herring, RN, MSN, CPNP, CPON, Vannie E. Cook Jr., Children’s
Cancer and Hematology Clinic, McAllen, TX
Daniel Indelicato, MD, University of Florida, Jacksonville, FL
Jennifer Levine , MD, Columbia University Medical Center, New York, NY
Alberto Pappo, MD, St. Jude Children’s Hospital, Memphis, TN
Lona Roll, RN, MSN, Christus Santa Rosa, San Antonio, TX
Michael Rytting, MD, MD Anderson Cancer Center, Houston, TX
Lewis Silverman, MD, Dana Farber Institute, Boston MA
David Thomas, FRACP, PhD, Peter McCallum Center Research Institute,
Melbourne, Australia
Ronald Williams, MD, University of Texas Health Science Center, San Antonio, TX
Matthew Zachary, I’m Too Young for This! Cacner Foundation, New York, NY

4. FACULTY DISCLOSURE
Methodist Healthcare controls the content and production of its CME activities and attempts to
assure the presentation of balanced, objective information. In accordance with the Standards
for Commercial Support established by the Accreditation Council for Continuing Medical
Education, the speakers have been asked to disclose any interest or affiliation with the
manufacturers of products or devices, which may be discussed in this presentation.
Speaker: Affiliation or Name of Company Conflict
Financial Interest: Resolved
Karen Albritton Grant/Research Cure Search Yes
Ronald Barr N/A
Archie Blyer Speaker Bureau Sigma Tau Yes
Grant/ Research AFLAC Foundation,
Livestrong Foundation
Sage Bolte N/A
Anu Dham Speaker Bureau Millennium Yes
Conrad Fernandez NA
Joan Haase NA
Ruth Anne Herring N/A
Daniel Indelicato N/A
Jennifer Levine N/A
Alberto Pappo Paid Consultant ZioPharm Oncology Yes
Lona Roll N/A
Michael Rytting N/A
Lewis Silverman N/A
David Thomas N/A
Ronald Williams N/A
Matthew Zachary N/A
The speakers have been asked to disclose whether his/her presentation will include discussion of
investigational or unlabeled uses of a product.
Jennifer Levine, M.D. will include discussion of investigational or unlabeled uses of a product on:
– Gonadotropin releasing hormone analogies

5. ACCREDITATION
Physicians:
Methodist Healthcare is accredited by the Texas Medical Association to provide
continuing medical education for physicians.
Methodist Healthcare designates this educational activity for a maximum of 10.5 AMA
PRA Category 1 Credits™. Physicians should only claim credit commensurate with the
extent of their participation in the activity.
** This presentation has been designated by Methodist Healthcare for 1 hour of
education in medical ethics and/or professional responsibilities.
Nursing:
Methodist Healthcare System is an approved provider of continuing nursing education by
the Texas Nurses Association, an accredited approver by the American Nurses
Credentialing Center’s Commission on Accreditation. Participants attending the entire
activity and completing an evaluation will be awarded up to 10.5 contact hours.
Social Workers:
Methodist Healthcare System is recognized by the Texas State Board of Social Worker
Examiners as a Continuing Education Provider, CEU provider #: 4285.
www.dshs.state.tx.us/socialwork. Participants attending the entire activity and
completing an evaluation will be awarded up to 11 CEUs and 1 Ethics Hour for a total of
12 Hours.

6. Acknowledgements
Methodist Healthcare wishes to express appreciation to the following
companies for their commitment to continuing medical education by
supporting this conference:
Collaborating Supporters:
Methodist Children’s Hospital, San Antonio, TX
University of Texas Health Science Center, San Antonio, TX
Greehey Children’s Cancer Research Institute, University of Texas
Health Science Center, San Antonio, TX
Contributing Supporters:
Pediatric Specialists of Texas
Medical Education Grants:
Genzyme Corporation
Bristol-Meyers Squibb
Sigma Tau Pharmaceuticals, Inc.
Merck Sharp & Dohme Corp.
Education Grant: Supplemental grant issued to the South Texas
Pediatric MB-CCOP by the NCI to support activities leading to
improvement of survival of underserved populations affected by cancer.
Parent grant #: CA52771
Exhibitors: Scholarships Sponsor:
LIVESTRONG
Nurse Oncology Education Program
Paragon Hemophilia & Infusion Care
Rx Partners Pharmacy
Sigma Tau

7. Agenda
October 1, 2010
1:30 pm Registration/ Exhibits
2: 00 pm Welcome Remarks
2:05 pm Cancer Between Age 15 and 40: Progress at Last! Is Texas Contributing?
3:00 pm Young Adult Patient Perspective
ACUTE LEUKEMIAS
3:45 pm Pediatric-based therapy of Adolescents and Young Adults with A.L.L.
4:25 pm Miracle Therapy for Adults with Acute Lymphoblastic Leukemia … Not
5:05 pm Break/Exhibits
5:20 pm Update on Dana Farber Trials for AYA with Acute Leukemias
6:00 pm Acute Leukemia in the AYA population – Nursing Perspective
7:00- 8:30 pm Networking Reception
October 2, 2010
7:00 am Breakfast/Registration/ Exhibits
7:45a.m. Opening Remarks/ Housekeeping issues
ACCESS to CARE and SURVIVOR ISSUES
7:50 am Lessons Learned in Developing an AYA Oncology Center
8:35 am Informed Consent for the Treatment of Adolescents and Young Adults with
Cancer* (meets ethics requirement)
9:35 am Emotional and Sexual Aspects of Adolescents and Young Adults with Cancer
10:30 am Break/Exhibits
10:40 am Fertility Assessment and Interventions in Adolescents and Young Adults with
Cancer

8. Agenda Continued
October 2, 2010
BREAK OUT SESSIONS
11:20 am Barriers to the Care of Adolescents and Young Adults with Cancer in the Medical
Oncologist Office
11:20 am Accentuate the Positive: Fostering Resilience in Adolescents and Young Adults
with Cancer
12:00 pm Lunch/Exhibits
12:20- 1:00 pm Lunch presentation:
Cancer in Adolescents and Young Adults – An International Perspective
1:00 pm Lunch/Exhibits
SARCOMAS
1:15 pm Osteosarcomas and Ewing Sarcomas
2:00 pm Soft Tissue Sarcomas
2:40 pm Radiotherapy in the Treatment of Sarcomas in Adolescents and Young Adults
3:20 pm Break/ Exhibit
3:30 pm Surgery for the Treatment of Adolescents and Young Adults with Sarcomas
4:10 pm Closing Remarks and Evaluations